Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J. Neurol. Neurosurg. Psychiatry 57, 416–418 (1994).
Brooks, B. R., Miller, R. G., Swash, M. & Munsat, T. L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 1, 293–299 (2000).
de Carvalho, M. et al. The Awaji criteria for diagnosis of ALS. Muscle Nerve 44, 456–457 (2011).
Ludolph, A. et al. A revision of the El Escorial criteria — 2015. Amyotroph. Lateral Scler. Frontotemporal Degener. 16, 291–292 (2015).
Neary, D. & Snowden, J. Frontal lobe dementia, motor neuron disease, and clinical and neuropathological criteria. J. Neurol. Neurosurg. Psychiatry 84, 713–714 (2013).
Neary, D. et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51, 1546–1554 (1998).
Article CAS PubMed Google Scholar
Rascovsky, K. et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134, 2456–2477 (2011).
Article PubMed PubMed Central Google Scholar
Shefner, J. M. et al. A proposal for new diagnostic criteria for ALS. Clin. Neurophysiol. 131, 1975–1978 (2020).
Strong, M. J. et al. Amyotrophic lateral sclerosis — frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph. Lateral Scler. Frontotemporal Degener. 18, 153–174 (2017).
Article PubMed PubMed Central Google Scholar
Benatar, M. et al. Mild motor impairment as prodromal state in amyotrophic lateral sclerosis: a new diagnostic entity. Brain 145, 3500–3508 (2022).
Article PubMed PubMed Central Google Scholar
Benatar, M., Wuu, J., Andersen, P. M., Lombardi, V. & Malaspina, A. Neurofilament light: a candidate biomarker of pre-symptomatic ALS and phenoconversion. Ann. Neurol. 84, 130–139 (2018).
Article CAS PubMed Google Scholar
Bjornevik, K. et al. Prediagnostic neurofilament light chain levels in amyotrophic lateral sclerosis. Neurology 97, e1466–e1474 (2021).
Article PubMed PubMed Central Google Scholar
Smith, E. N. et al. Plasma neurofilament light levels show elevation two years prior to diagnosis of amyotrophic lateral sclerosis in the UK Biobank. Amyotroph. Lateral Scler. Frontotemporal Degener. 25, 170–176 (2024).
Article CAS PubMed Google Scholar
Benatar, M. et al. Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases. Brain 145, 27–44 (2022).
Boeve, B. F., Boxer, A. L., Kumfor, F., Pijnenburg, Y. & Rohrer, J. D. Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations. Lancet Neurol. 21, 258–272 (2022).
Article CAS PubMed Google Scholar
Benussi, A. et al. Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia. Alzheimers Dement. 18, 1408–1423 (2022).
Mitsumoto, H., Kasarskis, E. J. & Simmons, Z. Hastening the diagnosis of amyotrophic lateral sclerosis. Neurology 99, 60–68 (2022).
Article CAS PubMed Google Scholar
Benatar, M. & Wuu, J. Presymptomatic studies in ALS: rationale, challenges, and approach. Neurology 79, 1732–1739 (2012).
Article PubMed PubMed Central Google Scholar
Estevez-Fraga, C. et al. Expanding the spectrum of movement disorders associated with C9orf72 hexanucleotide expansions. Neurol. Genet. 7, e575 (2021).
Article PubMed PubMed Central Google Scholar
Daube, J. R. Electrodiagnostic studies in amyotrophic lateral sclerosis and other motor neuron disorders. Muscle Nerve 23, 1488–1502 (2000).
Article CAS PubMed Google Scholar
Swash, M. Shortening the time to diagnosis in ALS: the role of electrodiagnostic studies. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 1, S67–S72 (2000).
Johnsen, B. et al. Diagnostic criteria for amyotrophic lateral sclerosis: a multicentre study of inter-rater variation and sensitivity. Clin. Neurophysiol. 130, 307–314 (2019).
Article CAS PubMed Google Scholar
Petersen, R. C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 256, 183–194 (2004).
Article CAS PubMed Google Scholar
Benatar, M., Turner, M. R. & Wuu, J. Defining pre-symptomatic amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener. 20, 303–309 (2019).
Article PubMed PubMed Central Google Scholar
Brooks, B. R. The role of axonal transport in neurodegenerative disease spread: a meta-analysis of experimental and clinical poliomyelitis compares with amyotrophic lateral sclerosis. Can. J. Neurological Sci. 18, 435–438 (1991).
Grossman, M. et al. Frontotemporal lobar degeneration. Nat. Rev. Dis. Prim. 9, 40 (2023).
Leroy, M. et al. Characteristics and progression of patients with frontotemporal dementia in a regional memory clinic network. Alzheimers Res. Ther. 13, 19 (2021).
Article PubMed PubMed Central Google Scholar
Boeve, B. et al. The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology. Alzheimers Dement. 16, 22–36 (2020).
Olney, N. T. et al. Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration. Alzheimers Dement. 16, 49–59 (2020).
Barker, M. S. et al. Proposed research criteria for prodromal behavioural variant frontotemporal dementia. Brain 145, 1079–1097 (2022).
Article PubMed PubMed Central Google Scholar
Brooks, B. R. El Escorial World Federation of Neurology Criteria for the diagnosis of amyotrophic lateral sclerosis. J. Neurological Sci. 124, 96–107 (1994).
Taylor, L. J. et al. Is language impairment more common than executive dysfunction in amyotrophic lateral sclerosis? J. Neurol. Neurosurg. Psychiatry 84, 494–498 (2013).
Abrahams, S. Executive dysfunction in ALS is not the whole story. J. Neurol. Neurosurg. Psychiatry 84, 474–475 (2013).
Saxon, J. A. et al. Semantic dementia, progressive non-fluent aphasia and their association with amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 88, 711–712 (2017).
Kendler, K. S. The phenomenology of major depression and the representativeness and nature of DSM criteria. Am. J. Psychiatry 173, 771–780 (2016).
Tipton, P. W. et al. Differences in motor features of C9orf72, MAPT, or GRN variant carriers with familial frontotemporal lobar degeneration. Neurology 99, e1154–e1167 (2022).
Article CAS PubMed PubMed Central Google Scholar
Siuda, J., Fujioka, S. & Wszolek, Z. K. Parkinsonian syndrome in familial frontotemporal dementia. Parkinsonism Relat. Disord. 20, 957–964 (2014).
Article PubMed PubMed Central Google Scholar
Rowe, J. B., Holland, N. & Rittman, T. Progressive supranuclear palsy: diagnosis and management. Pract. Neurol. 21, 376–383 (2021).
Article PubMed PubMed Central Google Scholar
Espay, A. J. & Litvan, I. Parkinsonism and frontotemporal dementia: the clinical overlap. J. Mol. Neurosci. 45, 343–349 (2011).
Article CAS PubMed PubMed Central Google Scholar
de Pablo-Fernandez, E. et al. A clinicopathologic study of movement disorders in frontotemporal lobar degeneration. Mov. Disord. 36, 632–641 (2021).
Gasca-Salas, C. et al. Characterization of movement disorder phenomenology in genetically proven, familial frontotemporal lobar degeneration: a systematic review and meta-analysis. PLoS ONE 11, e0153852 (2016).
留言 (0)